1 ors that regulate the transition from primary to metastatic
cancer is a fundamental challenge.
2 Epithelial ovarian
cancer is a leading cause of death in gynecological cancers.
3 Ovarian
cancer is a lethal malignancy that has not seen a major thera
4 Thyroid
cancer is a major component cancer of Cowden syndrome (CS), a
5 activity of androgen receptor (AR) coregulators in prostate
cancer is an important mechanism driving disease progression
6 g in superior therapeutic efficacy.MEK inhibition in breast
cancer is associated with increased tumour infiltrating lymph
7 TCGA data set indicates that upregulation of DHX9 in breast
cancer is associated with poor survival.
8 Esophageal
cancer is characterized by early and frequent metastasis.
9 Thyroid
cancer is common, yet the sequence of alterations that promot
10 and timely and accurate detection of clinically significant
cancer is critical in positively affecting outcomes.
11 Early diagnosis of
cancer is decisive for its successful treatment.
12 ons significantly reduced, but also the onset of pancreatic
cancer is delayed.
13 Curative therapies are most successful when
cancer is diagnosed and treated at an early stage.
14 standing the risk factors and trends in posttransplant skin
cancer is fundamental to targeted screening and prevention in
15 Being diagnosed with and treated for
cancer is highly stressful and potentially traumatic.
16 The course of prostate
cancer is highly variable, and timely and accurate detection
17 , the role of alcohol drinking on outcomes in patients with
cancer is in its formative stages, and ASCO can play a key ro
18 The dynamic of
cancer is intimately linked to a dysregulation of the cell cy
19 As therapy against cancer stem cells in endometrial
cancer is lacking, the ability of anti-EMP2 IgG1 therapy to r
20 Discovery of first-in-class medicines for treating
cancer is limited by concerns with their toxicity and safety
21 Pancreatic
cancer is molecularly diverse, with few effective therapies.
22 Cardiovascular disease in patients with breast
cancer is of growing concern.
23 Differentiating it from pancreatic
cancer is of paramount importance.
24 Nevertheless,
cancer is often observed at high incidence across a range of
25 edding light on the crosstalk between allergic response and
cancer is paving the way for new avenues of treatment.
26 re their "causal" HPV infection that develops into cervical
cancer is poorly understood and practically unobservable.
27 The pathobiology of early squamous lung
cancer is poorly understood.
28 ciated fibroblasts (CAFs) confer chemoresistance in ovarian
cancer is poorly understood.
29 y of cancers in different locations of the gut, where colon
cancer is primarily driven by inflammation and the microbiome
30 ative adjuvant radiotherapy (aRT) in patients with prostate
cancer is still limited in the United States.
31 NTERPRETATION: The burden of CHCs in survivors of childhood
cancer is substantial and highly variable.
32 Colorectal
cancer is the commonest gastrointestinal carcinoma.
33 Human cervical
cancer is the fourth most common carcinoma in women worldwide
34 Lung
cancer is the leading cause of cancer death in the United Sta
35 Lung
cancer is the leading cause of cancer death in the United Sta
36 Lung
cancer is the leading cause of cancer-related deaths, primari
37 Breast
cancer is the most common cancer among women and 30% of patie
38 Thyroid
cancer is the most common cancer in Korea.
39 High-grade serous ovarian
cancer is the most common ovarian cancer type.
40 Lung
cancer is the most frequent cause of cancer-related deaths wo
41 Prostate
cancer is the second leading cause of cancer deaths in US men
42 Liver
cancer is the second leading cause of cancer mortality worldw
43 Primary liver
cancer is the second leading cause of cancer-related death wo
44 Follicular thyroid
cancer is the second most common differentiated thyroid cance
45 Although
cancer is typically associated with somatic variations, advan
46 cology, but their clinicopathologic significance in thyroid
cancer is unclear.
47 rks on mitochondrial DNA (mtDNA); but their contribution in
cancer is unidentified.
48 ther ITPP protects from distant metastases in primary colon
cancer is unknown.
49 Triple-negative breast
cancer is viewed clinically as an aggressive subgroup of brea
50 w these cells are regulated and what their specific role in
cancer is will provide insight for the development of approac